Fig. 5
From: A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia
Independent validation of the miR2PE-score in external multicenter cohorts. A summary of the samples used to validate the performance of miR2PE-score to classify PE versus normal samples and the confusion matrix in the Canada cohort (A) and the USA cohort (D). TPR, true positive rate; TNR, true negative rate; PPV, positive predictive value; NPV, negative predictive value; ACC, overall accuracy. A heatmap of the expression pattern of identified two miRNA biomarkers with the corresponding miR2PE-score and predicted label and true label in the Canada cohort (B) and the USA cohort (E). The ROC for the performance of the miR2PE-score in the Canada cohort (C) and the USA cohort (F). ROC, receiver operating characteristic curve